News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

EP. 1: Pathophysiology and Treatment Landscape of CLL

July 18th 2016

EP. 2: Increased Use of Targeted Therapies in CLL

July 18th 2016

EP. 3: Health Plans Encourage Use of Diagnostic Tests in CLL

July 18th 2016

EP. 4: Impact of Major Trials on CLL Treatment

July 18th 2016

EP. 5: Pathophysiology, Prognostic Factors, and Potential Risks That Influence Treatment in CLL

July 18th 2016

EP. 6: Flexibility in Treatment Options for CLL

July 18th 2016

EP. 7: Combination Treatments in CLL

July 18th 2016

EP. 8: Factors That Influence Up-front Therapy and Sequencing in CLL

July 18th 2016

EP. 9: Impact of Novel Agents on Coverage Decisions in CLL

July 18th 2016

EP. 10: Efficacy and Safety Considerations to Improve the Value of Treatment in CLL

July 18th 2016

EP. 11: RESONATE-2 Trial: Safety and Efficacy Updates

July 18th 2016

EP. 12: Patient Selection for Treatment With Ibrutinib in CLL

July 18th 2016

EP. 13: Treatment Options for Older Patients With CLL

July 18th 2016

EP. 14: Expanding Options in Treating CLL

July 18th 2016

EP. 15: How Do Payers Assess Value of Treatments in CLL?

July 18th 2016

EP. 16: The Changing Treatment Paradigm in CLL

July 18th 2016

EP. 17: Safety of CLL Treatment and Reimbursement

July 18th 2016

EP. 18: Safety and Efficacy Considerations in CLL

July 18th 2016

EP. 19: Looking to the Future in CLL Treatments

July 18th 2016

EP. 20: Value of Real-World Data in CLL Treatment

July 18th 2016

EP. 21: Outcomes From the RESONATE 2 and HELIOS Trials - Clinical Impact

July 18th 2016

EP. 22: Unmet Needs and the Increased Use of Targeted Therapy in CLL

July 18th 2016

EP. 23: Diagnostic Testing and Evidence-Based Treatment in Cancer Care

July 18th 2016

EP. 24: Influence of Treatment Modality on Outcomes in CLL

July 18th 2016

EP. 25: Weighing the Value of Treatments in CLL

July 18th 2016

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.